Acid‐inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori‐negative healthy subjects

Background: Omeprazole 20 mg once daily (o.d.) and lansoprazole 30 mg o.d. have similar acid‐inhibitory effects in healthy Helicobacter pylori‐positive subjects. However, little is known about the acid‐inhibitory effects of the o.d. and twice daily (b.d.) doses in H. pylori‐negative subjects. Aim: T...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 1998-04, Vol.12 (4), p.329-335
Hauptverfasser:	Geus, Mulder, Nicolai, Boomgaard, D. M. Van Den, Lamers
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles Administration, Oral Adult Anti-Ulcer Agents - administration & dosage Anti-Ulcer Agents - pharmacology Anti-Ulcer Agents - therapeutic use Biological and medical sciences Cross-Over Studies Digestive system Double-Blind Method Gastric Acid - metabolism Helicobacter pylori Humans Lansoprazole Medical sciences Omeprazole - administration & dosage Omeprazole - analogs & derivatives Omeprazole - pharmacology Omeprazole - therapeutic use Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!